These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38368039)

  • 41. Obstructive sleep apnea and hypertrophic cardiomyopathy: a common and potential harmful combination.
    Nerbass FB; Pedrosa RP; Danzi-Soares NJ; Drager LF; Arteaga-Fernández E; Lorenzi-Filho G
    Sleep Med Rev; 2013 Jun; 17(3):201-6. PubMed ID: 23046848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Link MS; Maron MS; Maron BJ
    Circulation; 2023 Nov; 148(22):1797-1811. PubMed ID: 38011245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
    Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
    Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
    Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
    Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac Death.
    Sakhi R; Huurman R; Theuns DAMJ; Schinkel AFL; Assaf A; Szili-Torok T; Roos-Hesselink JW; Michels M; Yap SC
    Cardiology; 2021; 146(2):207-212. PubMed ID: 33477163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
    Lynch A; Tatangelo M; Ahuja S; Steve Fan CP; Min S; Lafreniere-Roula M; Papaz T; Zhou V; Armstrong K; Aziz PF; Benson LN; Butts R; Dragulescu A; Gardin L; Godown J; Jeewa A; Kantor PF; Kaufman BD; Lal AK; Parent JJ; Richmond M; Russell MW; Balaji S; Stephenson EA; Villa C; Jefferies JL; Whitehill R; Conway J; Howard TS; Nakano SJ; Rossano J; Weintraub RG; Mital S
    J Am Coll Cardiol; 2023 Mar; 81(11):1035-1045. PubMed ID: 36922089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Maron BJ
    Am J Cardiol; 2024 Feb; 212S():S64-S76. PubMed ID: 38368038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New trends in treatment of hypertrophic cardiomyopathy.
    Hagège AA; Desnos M
    Arch Cardiovasc Dis; 2009 May; 102(5):441-7. PubMed ID: 19520330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
    Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Olivotto I; Casey SA; Arretini A; Tomberli B; Garberich RF; Link MS; Chan RHM; Lesser JR; Maron BJ
    J Am Coll Cardiol; 2016 Mar; 67(12):1399-1409. PubMed ID: 27012399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypertrophic obstructive cardiomyopathy.
    Veselka J; Anavekar NS; Charron P
    Lancet; 2017 Mar; 389(10075):1253-1267. PubMed ID: 27912983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
    Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the impact of atrial fibrillation on symptoms and quality of life in hypertrophic cardiomyopathy.
    Rowin EJ; Wadid M; Maron MS; White M; Hook BG; Harnish P; Silver JS; Reynolds MR; Maron BJ
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):654-663. PubMed ID: 38288888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
    Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
    Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
    Pujades-Rodriguez M; Guttmann OP; Gonzalez-Izquierdo A; Duyx B; O'Mahony C; Elliott P; Hemingway H
    PLoS One; 2018; 13(1):e0191214. PubMed ID: 29324812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
    Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV
    Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS; Chan RH; Hausvater A; Wang W; Rastegar H; Maron BJ
    Am J Cardiol; 2017 Dec; 120(12):2256-2264. PubMed ID: 29111210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Abdelfattah OM; Martinez M; Sayed A; ElRefaei M; Abushouk AI; Hassan A; Masri A; Winters SL; Kapadia SR; Maron BJ; Rowin E; Maron MS
    JACC Clin Electrophysiol; 2022 Nov; 8(11):1417-1427. PubMed ID: 36424010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.